| SC 13D/A | 2018-07-31 | ROSE WILLIAM | REATA PHARMACEUTICALS INC | 3,194,724 | 12.4% | EDGAR |
| SC 13D/A | 2018-07-31 | Huff James Warren | REATA PHARMACEUTICALS INC | 1,096,473 | 4.5% | EDGAR |
| SC 13G | 2018-02-01 | BlackRock Inc. | REATA PHARMACEUTICALS INC | 1,203,993 | 6.1% | EDGAR |
| SC 13D/A | 2017-12-29 | CPMG Inc | REATA PHARMACEUTICALS INC | 4,605,380 | 21.4% | EDGAR |
| SC 13D/A | 2017-12-08 | ROSE WILLIAM | REATA PHARMACEUTICALS INC | 1,242,037 | 6.6% | EDGAR |
| SC 13D/A | 2017-11-13 | CPMG Inc | REATA PHARMACEUTICALS INC | 4,361,180 | 20.3% | EDGAR |
| SC 13D/A | 2017-11-13 | Novo Holdings A/S | REATA PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2017-08-11 | AbbVie Inc. | REATA PHARMACEUTICALS INC | 720,937 | 4.9% | EDGAR |
| SC 13D/A | 2017-08-03 | CPMG Inc | REATA PHARMACEUTICALS INC | 4,361,180 | 21.5% | EDGAR |
| SC 13D/A | 2017-08-03 | Novo Holdings A/S | REATA PHARMACEUTICALS INC | 1,794,763 | 9.1% | EDGAR |
| SC 13D/A | 2017-08-02 | Huff James Warren | REATA PHARMACEUTICALS INC | 981,359 | 5.1% | EDGAR |
| SC 13D/A | 2017-08-02 | ROSE WILLIAM | REATA PHARMACEUTICALS INC | 3,185,538 | 15.4% | EDGAR |
| SC 13D/A | 2017-07-12 | ROSE WILLIAM | REATA PHARMACEUTICALS INC | 3,183,306 | 18.9% | EDGAR |
| SC 13D/A | 2017-06-26 | CPMG Inc | REATA PHARMACEUTICALS INC | 4,361,180 | 26.5% | EDGAR |
| SC 13D/A | 2017-06-26 | Novo Holdings A/S | REATA PHARMACEUTICALS INC | 1,794,763 | 11.3% | EDGAR |
| SC 13D/A | 2017-06-15 | Novo A/S | REATA PHARMACEUTICALS INC | 2,994,763 | 18.3% | EDGAR |
| SC 13G/A | 2017-05-01 | AbbVie Inc. | REATA PHARMACEUTICALS INC | 1,190,473 | 8.6% | EDGAR |
| SC 13D/A | 2017-03-06 | CPMG Inc | REATA PHARMACEUTICALS INC | 3,161,180 | 20.9% | EDGAR |
| SC 13D/A | 2017-03-03 | Huff James Warren | REATA PHARMACEUTICALS INC | 947,165 | 6.5% | EDGAR |
| SC 13D/A | 2017-03-03 | ROSE WILLIAM | REATA PHARMACEUTICALS INC | 3,179,427 | 19.9% | EDGAR |